Evaluation of NCS-1, DARPP-32, and neurotrophins in hippocampus and prefrontal cortex in rats submitted to sepsis

Synapse

Volumn 68, Issue 10, 2014, Pages 474-479

  Comim, Clarissa M ^a   Silva, Napoleão C ^a   Mina, Francielle ^a   Dominguini, Diogo ^a   Scaini, Giselli ^a   Morais, Meline O S ^a   Rosa, Daniela V ^b   Magno, Luiz Alexandre V ^b   Streck, Emilio L ^a   Romano Silva, Marco A ^b   Quevedo, João ^a,c   Dal Pizzol, Felipe ^a  

^a UNIVERSITY OF SOUTHERN SANTA CATARINA   (Brazil)

^b FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^c UNIVERSITY OF TEXAS MEDICAL SCHOOL   (United States)

Author keywords

BDNF; Brain; Cognitive impairment; NGF

Indexed keywords

BRAIN DERIVED NEUROTROPHIC FACTOR; DOPAMINE CAMP REGULATED PHOSPHOPROTEIN 32; NERVE GROWTH FACTOR; NEURONAL CALCIUM SENSOR; NEUROTROPHIN; PHOSPHOPROTEIN; PHOSPHOPROTEIN DARPP 32; UNCLASSIFIED DRUG; FREQUENIN CALCIUM SENSOR PROTEINS; NEUROPEPTIDE; PPP1R1B PROTEIN, RAT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; ENZYME LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IMMUNOBLOTTING; MALE; NONHUMAN; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; SEPSIS; ANIMAL; DISEASE MODEL; METABOLISM; TIME; WISTAR RAT;

ANIMALS; BRAIN-DERIVED NEUROTROPHIC FACTOR; DISEASE MODELS, ANIMAL; DOPAMINE AND CAMP-REGULATED PHOSPHOPROTEIN 32; ENZYME-LINKED IMMUNOSORBENT ASSAY; HIPPOCAMPUS; IMMUNOBLOTTING; MALE; NERVE GROWTH FACTOR; NERVE GROWTH FACTORS; NEURONAL CALCIUM-SENSOR PROTEINS; NEUROPEPTIDES; PREFRONTAL CORTEX; RATS, WISTAR; SEPSIS; TIME FACTORS;

EID: 84906058305     PISSN: 08874476     EISSN: 10982396     Source Type: Journal    
DOI: 10.1002/syn.21760     Document Type: Article

References (47)

1. Albert KA, Hemmings HC Jr, Adamo AI, Potkin SG, Akbarian S, Sandman CA, Cotman CW, Bunney WE Jr, Greengard P. 2002. Evidence for decreased DARPP-32 in the prefrontal cortex of patients with schizophrenia. Arch Gen Psychiatry 59:705-712.
2. Auld DS, Mennicken F, Quirion R. 2001. Nerve growth factor rapidly induces prolonged acetylcholine release from cultured basal forebrain neurons: Differentiation between neuromodulatory and neurotrophic influences. J Neurosci 2:3375-3382.
3. Barichello T, Belarmino E Jr, Comim CM, Cipriano AL, Generoso JS, Savi GD, Stertz L, Kapczinski F, Quevedo J. 2010. Correlation between behavioral deficits and decreased brain-derived neurotrophic [correction of neurotrofic] factor in neonatal meningitis. J Neuroimmunol 223:73-76.
4. Bergson C, Levenson R, Goldman-Rakic PS, Lidow MS. 2003. Dopamine receptor-interacting proteins: The Ca(2+) connection in dopamine signaling. Trends Pharmacol Sci 24:486-492.
5. Biff D, Petronilho F, Constantino L, Vuolo F, Zamora-Berridi GJ, Dall'Igna DM, Comim CM, Quevedo J, Kapczinski F, Dal-Pizzol F. 2013. Correlation of acute phase inflammatory and oxidative markers with long-term cognitive impairment in sepsis survivors rats. Shock 40:45-48.
6. Boulanger LM. 2009. Immune proteins in brain development and synaptic plasticity. Neuron 64:93e109.
7. Bramham CR, Messaoudi E. 2005. BDNF function in adult synaptic plasticity: The synaptic consolidation hypothesis. Prog Neurobiol 76:99-125.
8. Burgoyne RD. 2007. Neuronal calcium sensor proteins: Generating diversity in neuronal Ca2+ signalling. Nat Rev Neurosci 8:182-193.
9. Cassol-Jr OJ, Comim CM, Constantino LS, Rosa DV, Mango LA, Stertz L, Kapczinski F, Romano-Silva MA, Quevedo J, Dal-Pizzol F. 2011. Acute low dose of MK-801 prevents memory deficits without altering hippocampal DARPP-32 expression and BDNF levels in sepsis survivor rats. J Neuroimmunol 230:48-51.
10. Chen XL, Zhong ZG, Yokoyama S, Bark C, Meister B, Berggren PO, Roder J, Higashida H, Jeromin A. 2001. Overexpression of rat neuronal calcium sensor-1 in rodent NG108-15 cells enhances synapse formation and transmission. J Physiol 532:649-659.
11. Comim CM, Constantino LC, Barichello T, Streck EL, Quevedo J, Dal-Pizzol F. 2009a. Cognitive impairment in the septic brain. Curr Neurovasc Res 6:194-203.
12. Comim CM, Constantino LS, Petronilho F, de Souza B, Barichello T, Quevedo J, Dal-Pizzol F. 2009b. Effects of acute treatment with amphetamine in locomotor activity in sepsis survivor rats. J Neuroimmunol 25:145-147.
13. Comim CM, Cassol-Jr OJ, Constantino LC, Petronilho F, Constantino LS, Stertz L, Kapczinski F, Barichello T, Quevedo J, Dal-Pizzol F. 2010. Depressive-like parameters in sepsis survivor rats. Neurotox Res 17:279-286.
14. Comim CM, Constantino LS, Petronilho F, Quevedo J, Dal-Pizzol F. 2011. Aversive memory in sepsis survivor rats. J Neural Transm 118:213-217.
15. Cuello et al., 1989.
16. Francia N, Cirulli F, Chiarotti F, Antonelli A, Aloe L, Alleva E. 2006. Spatial memory deficits in middle-aged mice correlate with lower exploratory activity and a subordinate status: role of hippocampal neurotrophins. Eur J Neurosci 23:711-728.
17. Génin A, Davis S, Meziane H, Doyère V, Jeromin A, Roder J, Mallet J, Laroche S. 2001. Regulated expression of the neuronal calcium sensor-1 gene during long-term potentiation in the dentate gyrus in vivo. Neuroscience 106:571-577.
18. Goldstein BI, Collinger KA, Lotrich F, Marsland AL, Gill MK, Axelson DA, Birmaher B. 2011. Preliminary findings regarding proinflammatory markers and brain-derived neurotrophic factor among adolescents with bipolar spectrum disorders. J Child Adolesc Psychopharmacol 21:479-484.
19. Gomez M, De Castro E, Guarin E, Sasakura H, Kuhara A, Mori I, Bartfai T, Bargmann CI, Nef P. 2001. Ca2+ signaling via the neuronal calcium sensor-1 regulates associative learning and memory in C. elegans. Neuron 30:241-248.
20. Handley MT, Lian LY, Haynes LP, Burgoyne RD. 2010. Structural and functional deficits in a neuronal calcium sensor-1 mutant identified in a case of autistic spectrum disorder. PLoS One 5:e10534.
21. Huh CY, Danik M, Manseau F, Trudeau LE, Williams S. 2008. Chronic exposure to nerve growth factor increases acetylcholine and glutamate release from cholinergic neurons of the rat medial septum and diagonal band of Broca via mechanisms mediated by p75NTR. J Neurosci 28:1404-1409.
22. Iwashyna TJ, Ely EW, Smith DM, Langa KM. 2010. Long-term cognitive impairment and functional disability among survivors of severe sepsis. JAMA 304:1787-1794.
23. Kabbani N, Negyessy L, Lin R, Goldman-Rakic P, Levenson R. 2002. Interaction with neuronal calcium sensor NCS-1 mediates desensitization of the D2 dopamine receptor. J Neurosci 22:8476-8486.
24. Kaplan GB, Vasterling JJ, Vedak PC. 2010. Brain-derived neurotrophic factor in traumatic brain injury, post-traumatic stress disorder, and their comorbid conditions: Role in pathogenesis and treatment. Behav Pharmacol 21:427-437.
25. Kavelaars A, Cobelens PM, Teunis MA, Heijnen CJ. 2005. Changes in innate and acquired immune responses in mice with targeted deletion of the dopamine transporter gene. J Neuroimmunol 161:162-168.
26. Koh PO, Undie AS, Kabbani N, Levenson R, Goldman-Rakic PS, Lidow MS. 2003. Up-regulation of neuronal calcium sensor-1 (NCS-1) in the prefrontal cortex of schizophrenic and bipolar patients. Proc Natl Acad Sci USA 100:313-317.
27. Lewin GR, Barde YA. 1996. Physiology of the neurotrophins. Annu Rev Neurosci 19:289-317.
28. Marsland AL, Gianaros PJ, Abramowitch SM, Manuck SB, Hariri AR. 2008. Interleukin-6 covaries inversely with hippocampal grey matter volume in middle aged adults. Biol Psychiatry 64:484-490.
29. Mogi M, Togari A, Kondo T, Mizuno Y, Komure O, Kuno S, Ichinose H, Nagatsu T. 1999. Brain-derived growth factor and nerve growth factor concentrations are decreased in the substantia nigra in Parkinson's disease. Neurosci Lett 270:45-48.
30. Nagahara AH, Tuszynski MH. 2011. Potential therapeutic uses of BDNF in neurological and psychiatric disorders. Nat Rev Drug Discov 10:209-219.
31. Nishi A, Snyder GL, Greengard P. 1997. Bidirectional regulation of DARPP32 phosphorylation by dopamine. J Neurosci 17:8147-8155.
32. Olafsson P, Wang T, Lu B. 1995. Molecular cloning and functional characterization of the Xenopus Ca(2+)-binding protein frequenin. Proc Natl Acad Sci USA 92:8001-8005.
33. Opara EC. 2006. Oxidative stress. Dis Mon 52:183e98.
34. Ouimet CC, LaMantia AS, Goldman-Rakic P, Rakic P, Greengard P. 1992. Immunocytochemical localization of DARPP-32, a dopamine and cyclic-AMP-regulated phosphoprotein, in the primate brain. J Comp Neurol 323:209-218.
35. Pehar M, Vargas MR, Robinson KM, Cassina P, England P, Beckman JS, Alzari PM, Barbeito L. 2006. Peroxynitrite transforms nerve growth factor into an apoptotic factor for motor neurons. Free Radical Biol Med 41:1632-1644.
36. Pongs O, Lindemeier J, Zhu XR, Theil T, Engelkamp D, Krah-Jentgens I, Lambrecht HG, Koch KW, Schwemer J, Rivosecchi R. 1993. Frequenin-A novel calcium-binding protein that modulates synaptic efficacy in the Drosophila nervous system. Neuron 11:15-28.
37. Rosa DV, Souza RP, Souza BR, Motta BS, Caetano F, Jornada LK, Feier G, Jeromin A, Gomez MV, Quevedo J, Romano-Silva MA. 2007. NCS-1 expression in rat brain after electroconvulsive stimulation. Neurochem Res 32:81-85.
38. Ruan L, Lau BW, Wang J, Huang L, Zhuge Q, Wang B, Jin K, So KF. 2013 Neurogenesis in neurological and psychiatric diseases and brain injury: From bench to bedside. Prog Neurobiol S0301-0082:00146-00149.
39. Saab BJ, Georgiou J, Nath A, Lee FJ, Wang M, Michalon A, Liu F, Mansuy IM, Roder JC. 2009. NCS-1 in the dentate gyrus promotes exploration, synaptic plasticity, and rapid acquisition of spatial memory. Neuron 63:643-656.
40. Schaad NC, De Castro E, Nef S, Hegi S, Hinrichsen R, Martone ME, Ellisman MH, Sikkink R, Rusnak F, Sygush J, Nef P. 1996. Direct modulation of calmodulin targets by the neuronal calcium sensor NCS-1. Proc Natl Acad Sci USA 93:9253-9258.
41. Seeman P. 1992. Dopamine receptor sequences. Therapeutic levels of neuroleptics occupy D2 receptors, clozapine occupies D4. Neuropsychopharmacology 7:261-284.
42. Sippy T, Cruz-Martin A, Jeromin A, Schweizer FE. 2003. Acute changes in short-term plasticity at synapses with elevated levels of neuronal calcium sensor-1. Nat Neurosci 6:1031-1038.
43. Streck EL, Comim CM, Barichello T, Quevedo J. 2008. The septic brain. Neurochem Res 33:2171-2177.
44. Svenningsson et al., 2002.
45. Svenningsson P, Nishi A, Fisone G, Girault JA, Nairn AC, Greengard P. 2004. DARPP-32: An integrator of neurotransmission. Annu Rev Pharmacol Toxicol 44:269-296.
46. Tuon L, Comim CM, Petronilho F, Barichello T, Izquierdo I, Quevedo J, Dal-Pizzol F. 2008. Time-dependent behavioral recovery after sepsis in rats. Int Care Med 34:1724-1731.
47. Zuccato C, Ciammola A, Rigamonti D, Leavitt BR, Goffredo D, Conti L, MacDonald ME, Friedlander RM, Silani V, Hayden MR, Timmusk T, Sipione S, Cattaneo E. 2001. Loss of huntingtin-mediated BDNF gene transcription in Huntington's disease. Science 293:493-498.